is jardiance a glp-1 receptor agonist agonists and next-generation metabolic hormone therapies in chronic kidney disease Is Jardiance a GLP-1? 2026

doi: 10.1161/CIR.0000000000001209

Short-acting drugs primarily lower postprandial blood glucose levels by slowing gastric emptying, while long-acting GLP-1 RAs are more effective at reducing fasting blood glucose levels, mainly by promoting insulin secretion and inhibiting glucagon release

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) improve biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomised controlled trials

doi: 10.1152/ajpregu.00460.2015 86 ChanSWLinGYewDTYeungCKRuddJA

We now know after more than 15 years of GLP-1 therapy that we can see cardioprotection, reduction in blood pressure, and we know we can see a reduction in body weight, Davies said

And it's also easy to forget that though a lot of people are using this for weight loss, most are using it for diabetes and may have other comorbid conditions that make them more susceptible to some of these rare side effects, Dr